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Internationally adopted children (IAC) require thorough health assessments at time
of arrival in the host country. As these children are at higher risk for infectious
diseases, such as gastrointestinal parasites, tuberculosis, hepatitis, syphilis, and human
immunodeficiency virus, early diagnosis of infectious diseases is fundamental for the
optimal management of the child and, also, to reduce the risk of transmission to
the adopting community. Comparative analysis of the screening protocols adopted in
Europe, the United States, and Canada revealed different approaches to the adopted
children. A homogeneous and internationally shared standard of care in the management
of IAC should be provided.
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INTRODUCTION
Infectious diseases are commonly reported in internationally adopted children (IAC) (1), and their
need for rapid, cautious, and thorough screenings has been underlined by several authors (1–5).
A recent Italian study indicated that clinical conditions affecting IAC, ranging from congenital
malformations, to complex infectious diseases, such as tuberculosis infection (observed in 15% of
children included) and parasitosis (inmore than 20%), to non-severe and easily treatable infections,
such asMolluscum contagiosum and fungal skin infections, have been frequently reported. Notably,
about 40% of IAC presented at least one infectious disease (2).
Although IAC require medical evaluation and health certifications before adoption, many
diseases may remain undiagnosed (3–5).
Early diagnosis of infectious diseases is crucial both for the optimal management of IAC and to
reduce risk of transmission to the community (1, 6, 7). Cases of transmission of the Hepatitis A and
Hepatitis B viruses, scabies, tuberculosis, Tinea capitis/corporis, and measles to adoptive families
have been reported in the literature (1, 6, 7).
A narrative review of the literature was conducted to identify and compare the screening
protocols used by different countries and to discuss the major discrepancies between them.
METHODS
Post-adoption screening protocols were identified by searching the guidelines websites and
national adoption association websites of countries reported to receive the highest number of
IAC (United States, Italy, Spain, Canada, and France) (8). Moreover, PubMed was consulted
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with the search strategy: (international∗OR abroad) AND
(“adopted children” OR adoption OR adoptees) AND
(“infectious diseases” OR infection∗). The reference lists of
the retrieved articles were analyzed. A comparison among the
retrieved protocols was performed, focusing on screening for
infectious diseases. Moreover, a narrative review of the literature
was performed to discuss discrepancies.
RESULTS
Six different protocols were identified (9–14), published in the
United Kingdom (UK), Spain, Italy, Canada, France, and the
United States (US). Four protocols were retrieved by searching
national adoption association websites (10–12, 14) and two
by searching the reference lists of results from PubMed (9–
13). Except for the French protocol, which is provided by
the Centre Hospitalier Universitaire de Nantes (13), all the
others were national protocols (9–12, 14). The English protocol
was published in 2004 (9), the Spanish protocol in 2008 (10),
and the four others between 2013 and 2017 (11–14). Their
recommendations have been summarized in Table 1.
HISTORY
All the retrieved protocols include a proper analysis of history to
describe the adoption process, the child’s life before adoption, any
host institutions where the child lived, the child’s psychophysical
development, and any certified vaccinations. Recent and remote
pathological anamnesis, previous laboratory tests, instrumental
examinations, and specialist evaluations, whenever available, are
necessary. Additionally, clinical histories of the biological family
need to be reviewed and added to the report (9–14).
SKIN PROBLEMS
A global clinical evaluation should be performed with particular
attention to skin and genital examination (9–14).
Skin infections in IAC are very common (6); having lived
in an overcrowded institution and coming from a tropical
country are the main risk factors for this type of infection. The
most frequently reported dermatological disease is Tinea capitis
infection, followed byMolluscum contagiosum, pediculosis of the
head, and impetigo; scabies is frequently observed and should
be promptly diagnosed and treated (6, 7). Skin examination is
also crucial to detect a Bacille Calmette Guerin (BCG) scar and




While the tuberculin skin test (TST) is the first choice in the UK,
Spain, Italy, and France (9–11, 13), Interferon-γ release assays
(IGRA) can be an acceptable screening alternative in Canada and
the US in children older than 5 and 2 years, respectively (12, 14).
HAV
Screening for hepatitis A (HAV) is not routinely recommended in
IAC in UK and Italy (9, 11), but it is suggested in Canada France,
and the US (12–14) and in IAC from Latin America arriving in
Spain (10).
HBV
HBV screening is recommended by all of the guidelines reviewed.
Italy, Canada, and the US recommend HBsAg and HBsAb (11,
12, 14), whereas the UK, Spain, and France also include HBcAb
(9, 10, 13). The UK, Italy, Canada, and the US recommend
repeating the serology after a window period if the first test is
negative (9, 11, 12, 14).
Malaria
Only the UK protocol recommends routine screening for malaria
upon arrival in all IAC coming from an endemic area (9), while all
the other protocols suggest it only in IAC coming from endemic
areas with fever (13) and/or hepato-splenomegaly (10–12, 14).
Other Parasitoses
An ova and parasite exam on three stool samples is routinely
recommended by all of the protocols, except for that in the
UK, which recommends the test only to children who have
lived in poor sanitary conditions, have been institutionalized,
or have an anamnestic history of diarrhea (9). Serologic testing
for Strongyloides spp. and Toxocara canis is recommended in
children where there is clinical suspicion or with eosinophilia and
a negative ova and parasite exam in Italy and the US (11, 14); only
in Canada is Strongyloides spp. routinely investigated in all IAC
coming from Africa and Southeast Asia (12).
Serologic testing for Schistosoma is indicated in Canada and
the US in IAC coming from endemic areas (12, 14).
Serologic testing for Trypanosoma cruzi is routinely
performed only in Spain and in US IAC (10, 14) coming
from endemic countries, while in other countries this test is not
recommended (9, 11–13).
Anti-cysticercus IgG antibodies are not recommended by
any protocol, not even among IAC coming from endemic
countries (9–14).
Syphilis
All the retrieved protocols recommend screening for syphilis,
but there is no concordance as regards the choice of treponemal
or nor-treponemal antibodies. Only non-treponemal serologic
testing is recommended in the UK, Spain, and Canada (9, 10,
12); both treponemal and non-treponemal tests are routinely
indicated in France and in the US (13, 14). The Italian protocol
does not specify the serologic pattern required (11).
DISCUSSION
This paper focuses on the screening protocols for infectious
diseases in newly arrived IAC. It is important to specify that
many other issues must be considered when managing IAC, such
as immunization coverage, auxo-endocrinological problems, and
other non-infectious diseases.
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TABLE 1 | Laboratory microbiological tests recommended in different screening protocols.
Laboratory tests UK 2004 (9) Spain 2008 (10) Italy 2013 (11) Canada 2014 (12) France 2015 (13) US 2017 (14)
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HBV, Hepatitis B virus; HCV, Hepatitis C virus; HAV, Hepatitis A virus; HIV, Human Immunodeficiency Virus; TST, tuberculin skin test; IGRA, Interferon Gamma Release Assay.
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To the best of our knowledge, this is the first study comparing
existing protocols for the screening of infectious diseases in
IAC. A limitation of this study is that some protocols may
have been missed by our research and that the comparison
among the protocols may be affected by the different levels
of methodological quality and different years of publication.
Moreover, these protocols might not reflect the common practice
in these countries, since heterogeneity has been reported among
different centers in the same country, and more recent evidence
might guide current management (2).
Most protocols were provided on a national level, whereas
in France, a systematic national approach does not exist, and
we reported the regional approach of a Medical Guidance for
Adopted Children Consultation (13).
All the protocols report sets of screening tests that allow
early detection of serious infectious conditions and those most
commonly reported among IAC (9–14).
All the retrieved protocols recommend screening for human
immunodeficiency virus (HIV), Hepatitis B virus (HBV),
Hepatitis C virus (HCV), Tuberculosis, syphilis, and intestinal
parasites (9–14).
The main discrepancies among the protocols regard the
recommendations for screening of the Hepatitis A virus (HAV),
malaria, and other parasitic infections.
HAV serology testing is not required by the UK protocol and
is recommended only in children coming from an endemic area
by Spanish protocol, whereas it is routinely recommended for
all IAC by the other protocols. HAV infection among IAC is
frequent, and cases of transmission to adoptive families have
been reported (15–19). In an American study including 656
IAC, 4.6% were positive for HAV infection, even if they did
not show any symptoms (15). They came mostly from Ethiopia
and Guatemala (15). This screening may be important so that
preventive measures can be started promptly, since many cases
of HAV have been reported among the components of adoptive
families (15–19).
Among the retrieved protocols, only the UK protocol
recommends screening for malaria in IAC coming from endemic
areas (9). The introduction of a screening test for malaria in
IAC coming from malaria-endemic countries has also recently
been supported in Italy after several cases were reported of
asymptomatic children with malaria coming from the African
continent (20). Either Polymerase Chain Reaction (PCR) or thin
and thick strip microscopy have been reported as valid screening
tests (20, 21).
Intestinal parasitic infections are very common in IAC: up
to 27% of children arriving in the US may have one or more
parasitic infections (1, 18, 22). In Italy, the prevalence of intestinal
parasitic infections among IAC is 23% (3). The most frequently
observed parasitic infections are Giardia lamblia and Toxocara
canis (1, 18, 22). All the protocols routinely recommend an ova
and parasite exam on three stool samples, except for the British
one, which indicates this exam only whether a clinical suspicion
is posed.
Only some of the protocols recommend serology testing for
Strongyloides spp. and Schistosoma spp. where there is clinical
suspicion or when the child comes from an endemic area. The
recently published European Centre for Disease Prevention and
Control (ECDC) protocol for screening of infectious diseases
in migrants recommends screening of Strongyloides spp. and
Schistosoma spp. among all migrants coming from endemic
areas (23).
Other relevant differences among the protocols regard the
choice of the elective test for the screening of latent tuberculosis
infection (LTBI) and syphilis and the specific antibodies and the
timing of serology of HBV.
Since many IAC have been vaccinated with BCG and have
undergone numerous TSTs, the TST results are difficult to
interpret, and discrepancies between TST and IGRA have
frequently been reported (24, 25). Higher rates of positive TST
were observed in children recently vaccinated with BCG, while
TST positivity rates were less frequent in those who had been
vaccinated less recently (15 years before) (26).
The ECDC protocol for screening and vaccination for
infectious diseases in newly arrived migrants (either adults or
children) to European Union countries indicates either the use
of TST or IGRA but does not specify the preferred test per
age (23).
It has been reported that IGRA showed higher specificity
overall than TST, but it may have lower sensitivity in children
under 5 years of age (1, 3, 24). For this reason, the US protocol
and the recent Italian guidelines for the diagnosis of tuberculosis
in migrants prefer the use of TST for children <5 years of age
(27). On the other hand, some experts suggest the use of only
IGRA also in children as young as 2 years if a good follow-up
can be assured (28). Moreover, IGRA has been reported to be
preferred when IAC are unlikely to return for TST reading (7, 8).
In a review of cost-effectiveness studies, LTBI screening
in migrants was reported to be cost-effective according to
seven studies, especially in young subjects from high-incidence
countries. IGRA was the most cost-effective test for LTBI
screening in migrants in four studies (29).
The prevalence of HBV infection among adopted children has
been estimated to be around 2–5% (18, 30). It is essential to detect
the infection in order to manage the infected child and to avoid
contagion of adopting families.
Discrepancies have been found regarding the antibodies
required and the timing.
During the window period, the only marker of acute infection
is anti-HBc, which is highly specific for establishing the diagnosis
of acute infection (31). For this reason, Spain recommends
repeating the serology after 3–6 months if HBcAb has not been
tested at arrival (10).
The recent ECDC protocol for screening of infectious diseases
in migrants recommends dosing HBsAg, anti-HBc, and HBs-
Ab to migrants from intermediate-/high-prevalence countries
(≥2–≥5% HBsAg) (23).
The prevalence of syphilis amounted to 3% in two studies
conducted on IAC (1, 18). The use of only one type of test may be
insufficient for diagnosis because false-positive non-treponemal
test results occur with various medical conditions and because
treponemal test results remain positive long after syphilis has
been treated adequately and can be falsely positive with other
spirochetal diseases (32).
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Many factors may justify these discrepancies. These protocols
were published in different periods, with the British protocol
being produced in 2004 and the Spanish in 2008 (9, 10).
Therefore, new evidence may have been included in the
protocols more recently produced by Italy, the US, France, and
Canada (11–14).
Another relevant factor is that every receiving country deals
with heterogeneous groups of IAC in terms of country of origin
and age (1). This fact may affect the prevalence of infectious
diseases in each group. For example, the serologic testing for
Strongyloides spp. and Schistosoma spp. in IAC coming from
endemic areas is routinely recommended by the Spanish protocol
but not in the other countries. This may result from the high
number of and greater experience with children coming from
African countries (33).
Moreover, these features constantly change according to new
adoptive policies in the countries of origin and the incidence of
infectious diseases in that specific period (1). For these reasons,
the frequency of infectious diseases among IAC is not easily
measurable (1, 33).
Furthermore, the discrepancies between the screening
protocols reflect the lack of international consensus regarding
some areas, such as the appropriate test for LTBI (24, 25).
Furthermore, different studies conducted in the same country
report different screening protocols, showing that approaches
are not only internationally heterogeneous (2).
Cost-effectiveness studies have been performed that
documented the cost-effectiveness of some screening tests
in migrants (either children or adults), but further studies may
be needed focusing specifically on adopted children (22, 34).
Recently, the ECDC has produced guidance on screening and
vaccination for infectious diseases in newly arrived migrants
within the European Union (23). This document is a useful
instrument but has the limitation of dealing with both adults
and children and does not focus specifically on IAC, who are a
high-risk, unusual population.
A systematic approach categorized per country of origin and
age may be useful, to be integrated with the information coming
from the history and examination of the child.
Since the screening protocols used in different countries
are not homogenous, the introduction of an optimized
internationally shared protocol focusing on IAC would
be highly desirable to fill the potential gaps in local
protocols. Moreover, an international consensus on the
proper screening of LTBI in this group of children would be
highly desirable.
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